Efficiency, Productivity and Efficacy – when delivered reproducibly, can accelerate your Therapy

Explore our Systems

High performance electroporation platform for small to medium scale production of transiently expressed proteins

  • High efficiency and viability improves protein yields
  • Enhanced productivity reduces cell culture requirements
  • Rapidly transfect from 75 thousand to 700 million cells
  • Compatible with all MaxCyte static electroporation Processing Assemblies
  • Perfect platform for faster production of stable clones

3D VIEW

The next generation of the industry’s leading, clinically validated and scalable electroporation technology for complex cellular engineering.

  • Rapidly transfect from 75 thousand to 20 billion cells
  • 21CFR Part 11 enabled software
  • Established regulatory path supported by FDA Master File
  • Closed, cGMP-compliant, ISO-certified and CE-marked
  • MaxCyte’s proprietary Flow Electroporation™ Technology

3D VIEW

The industry’s leading scalable electroporation technology for high yield transient expression of complex proteins, vaccines and biologics.

  • Rapidly transfect from 75 thousand to 20 billion cells
  • High efficiency with flexible media strategies deliver significant cost savings
  • Improved yields, at scale, can decrease development timelines
  • Proprietary Flow Electroporation™ Technology
  • Faster production of stable clones
  • ISO-certified, and CE-marked

3D VIEW

Our Vision

ENABLE COMPLEX CELLULAR ENGINEERING TO TRANSFORM THE LIVES OF PATIENTS

Contact

Find out how the ExPERT platform can help accelerate your research needs!